Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
6.61
-0.43 (-6.11%)
At close: Apr 6, 2026, 4:00 PM EDT
6.50
-0.11 (-1.66%)
After-hours: Apr 6, 2026, 7:59 PM EDT
Artelo Biosciences Employees
Artelo Biosciences had 7 employees as of December 31, 2025. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change
1
Growth
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,839,857
Market Cap
5.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 1 | 16.67% |
| Jun 30, 2025 | 5 | 0 | - |
| Mar 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 6 | 0 | - |
| Sep 30, 2024 | 5 | 0 | - |
| Jun 30, 2024 | 5 | 0 | - |
| Mar 31, 2024 | 5 | 0 | - |
| Dec 31, 2023 | 6 | -1 | -14.29% |
| Sep 30, 2023 | 5 | 1 | 25.00% |
| Jun 30, 2023 | 5 | 1 | 25.00% |
| Mar 31, 2023 | 5 | 1 | 25.00% |
| Dec 31, 2022 | 7 | 2 | 40.00% |
| Sep 30, 2022 | 4 | -1 | -20.00% |
| Jun 30, 2022 | 4 | - | - |
| Mar 31, 2022 | 4 | - | - |
| Dec 31, 2021 | 5 | 2 | 66.67% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 36 |
| BiomX | 20 |
| Cardio Diagnostics Holdings | 17 |
| Purple Biotech | 10 |
| Ensysce Biosciences | 8 |
| Dermata Therapeutics | 8 |
| Ernexa Therapeutics | 7 |
| Mustang Bio | 4 |
ARTL News
- 7 days ago - Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 10 days ago - Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 10 days ago - Artelo Biosciences Stock Soars After Withdrawing SEC Filing - Benzinga
- 12 days ago - Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments - GlobeNewsWire
- 12 days ago - Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength - GlobeNewsWire
- 19 days ago - Nano-Cap Artelo Biosciences Stock Explodes — Glaucoma Study Collaboration Ignites Rally - Benzinga
- 19 days ago - Biotech Breakthroughs and Strategic Pivots Fuel Market Momentum - GlobeNewsWire
- 19 days ago - Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study - GlobeNewsWire